Successful Implementation of Perinatal HIV Prevention Guidelines: A Multistate Surveillance Evaluation

2001 ◽  
Author(s):  
Pascale M. Wortley ◽  
Mary Lou Lindegren ◽  
Patricia L. Fleming
Keyword(s):  
Hiv Prevention ◽  
Successful Implementation ◽  
Perinatal Hiv ◽  
Prevention Guidelines ◽  
Perinatal Hiv Prevention

scholarly journals Intrapartum Tenofovir and Emtricitabine Reduces Low-Concentration Drug Resistance Selected by Single-Dose Nevirapine for Perinatal HIV Prevention

2009 ◽  
Vol 25 (11) ◽  
pp. 1099-1106 ◽  
Author(s):  
Benjamin H. Chi ◽  
Giovanina M. Ellis ◽  
Namwinga Chintu ◽  
Ronald A. Cantrell ◽  
Moses Sinkala ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Single Dose ◽  
Hiv Prevention ◽  
Low Concentration ◽  
Perinatal Hiv ◽  
Single Dose Nevirapine ◽  
Perinatal Hiv Prevention

scholarly journals Effect of Nevirapine Toxicity on Choice of Perinatal HIV Prevention Strategies

2002 ◽  
Vol 92 (3) ◽  
pp. 365-366 ◽  
Author(s):  
Jeffrey S. A. Stringer ◽  
Moses Sinkala ◽  
Dwight J. Rouse ◽  
Robert L. Goldenberg ◽  
Sten H. Vermund
Keyword(s):  
Hiv Prevention ◽  
Prevention Strategies ◽  
Perinatal Hiv ◽  
Hiv Prevention Strategies ◽  
Perinatal Hiv Prevention

scholarly journals Long-Term Follow-Up of Children in the HIVNET 012 Perinatal HIV Prevention Trial

2013 ◽  
Vol 64 (5) ◽  
pp. 464-471 ◽  
Author(s):  
Maxensia Owor ◽  
Anthony Mwatha ◽  
Deborah Donnell ◽  
Philippa Musoke ◽  
Francis Mmiro ◽  
...  
Keyword(s):  
Hiv Prevention ◽  
Prevention Trial ◽  
Perinatal Hiv ◽  
Long Term Follow Up ◽  
Perinatal Hiv Prevention

An Integrated City-Driven Perinatal HIV Prevention Program Covering 1.8 Million Pregnant Women in Shenzhen, China, 2000 to 2010

2013 ◽  
Vol 40 (4) ◽  
pp. 329-334 ◽  
Author(s):  
Junmin Song ◽  
Tiejian Feng ◽  
Marc Bulterys ◽  
Dan Zhang ◽  
Christine Korhonen ◽  
...  
Keyword(s):  
Hiv Prevention ◽  
Pregnant Women ◽  
Prevention Program ◽  
Perinatal Hiv ◽  
Perinatal Hiv Prevention

Missed Opportunities for Perinatal HIV Prevention Among HIV-Exposed Infants Born 1996–2000, Pediatric Spectrum of HIV Disease Cohort

PEDIATRICS ◽  
2003 ◽  
Vol 111 (Supplement_1) ◽  
pp. 1186-1191 ◽  
Author(s):  
Vicki Peters ◽  
Kai-Lih Liu ◽  
Kenneth Dominguez ◽  
Toni Frederick ◽  
Sharon Melville ◽  
...  
Keyword(s):  
Drug Use ◽  
Hiv Prevention ◽  
Prenatal Care ◽  
Hiv Testing ◽  
Hiv Transmission ◽  
Illicit Drug ◽  
Missed Opportunities ◽  
Perinatal Hiv ◽  
Hiv Exposed ◽  
Perinatal Hiv Prevention

Objective. Despite dramatic reductions in perinatal human immunodeficiency virus (HIV) transmission in the United States, obstacles to perinatal HIV prevention that include lack of prenatal care; failure to test pregnant women for HIV before delivery; and lack of prenatal, intrapartum, or neonatal antiretroviral (ARV) use remain. The objective of this study was to describe trends in perinatal HIV prevention methods, perinatal transmission rates, and the contribution of missed opportunities for perinatal HIV prevention to perinatal HIV infection. Methods. We analyzed data obtained from infant medical records on 4755 HIV-exposed singleton deliveries in 1996–2000, from 6 US sites that participate in the Centers for Disease Control and Prevention’s Pediatric Spectrum of HIV Disease Project. HIV-exposed deliveries refer to deliveries in which the mother was known to have HIV infection during the pregnancy. Results. Of the 4287 women with data on prenatal care, 92% had prenatal care. From 1996 to 2000, among the 3925 women with prenatal care, 92% had an HIV test before delivery; the use of prenatal zidovudine (ZDV) alone decreased from 71% to 9%, and the use of prenatal ZDV with other ARVs increased from 6% to 70%. Complete data on maternal and neonatal ARVs were available for 3284 deliveries. Perinatal HIV transmission was 3% in 1651 deliveries with prenatal ZDV in combination with other ARVs, intrapartum ZDV, and neonatal ZDV; 6% in 1111 deliveries with prenatal, intrapartum, and neonatal ZDV alone; 8% in 152 deliveries with intrapartum and neonatal ZDV alone; 14% of 73 deliveries with neonatal ZDV only started within 24 hours of birth; and 20% in 297 deliveries with no prenatal, intrapartum, and neonatal ARVs. Complete data on prenatal events were available in 328 HIV-infected and 3258 HIV-uninfected infants. A total of 56% of mothers of HIV-infected infants had missed opportunities for perinatal HIV prevention versus 16% of mothers of HIV-uninfected infants. Forty-four percent of the infected infants were born to mothers who had prenatal care, a prenatal HIV diagnosis, and documented prenatal ARV therapy. Seventeen percent of women with reported illicit drug use had no prenatal care versus 3% of women with no reported drug use. In a multivariate analysis, maternal illicit drug use was significantly associated with lack of prenatal care. In a multivariate analysis, year of infant birth and the combination of lack of maternal HIV testing before delivery and lack of prenatal antiretroviral therapies were significantly associated with perinatal HIV transmission. Conclusions. Missed opportunities for perinatal HIV prevention contributed to more than half of the cases of HIV-infected infants. Prenatal care and HIV testing before delivery are major opportunities for perinatal HIV prevention. Illicit drug use was highly associated with lack of prenatal care, and lack of HIV testing before delivery was highly associated with perinatal HIV transmission.

scholarly journals What is new in perinatal HIV prevention?

2018 ◽  
Vol 30 (1) ◽  
pp. 144-151 ◽  
Author(s):  
Mary G. Fowler ◽  
Patricia Flynn ◽  
Jim Aizire
Keyword(s):  
Hiv Prevention ◽  
Perinatal Hiv ◽  
Perinatal Hiv Prevention

Perinatal HIV Prevention Outcomes in U.S.-Born Versus Foreign-Born Blacks, PSD Cohort, 1995–2004

2014 ◽  
Vol 17 (4) ◽  
pp. 1010-1018 ◽  
Author(s):  
Ranell L. Myles ◽  
Melissa Artstein-McNassar ◽  
Hazel D. Dean ◽  
Beverly Bohannon ◽  
Sharon K. Melville ◽  
...  
Keyword(s):  
Hiv Prevention ◽  
Foreign Born ◽  
Perinatal Hiv ◽  
Perinatal Hiv Prevention
Sign in / Sign up

Export Citation Format

Share Document